|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Contrast EUS Versus EUS Sono-Elastography in the Differentiation of Atypical Pancreatic Masses显示文摘 | Pierre H. Deprez Chun-Ping R. Yeung Birgit Weynand Cedric Gillain Jean-Fran?ois Gigot Catherine Hubert Yves Horsmans Ivan Borbath | 2007 | Gastrointestinal Endoscopy2007,,5: | 1 |
| 2 | Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depression disorder and health controls 显示文摘 | ConstantEL Adam S Gillain B | 2011 | Clin Neurol Neurosurg2011,113,4: | 1 |
| 3 | Cultural Values:The Interaction of Discourse显示文摘 | Gillain | 1990 | ELT Journal1990,,1: | 1 |
| 4 | T1455: Evaluation of Pancreatic Tumors With Contrast Enhanced-Endoscopic Ultrasonography and EUS-Strain Ratio Elastography显示文摘 | Abdenor Badaoui Ivan Borbath Tarik Aouattah Cedric Gillain Thierry De Ronde Pierre H. Deprez | 2010 | Gastrointestinal Endoscopy2010,,5: | 1 |
| 5 | Perisylvian dysgenesisclinical,EEG,MRI and glucose metabolism features in 10patients显示文摘 | Bogaert David P Gillain CA | 1998 | Brain1998,121,12: | 1 |
| 6 | Assessing the causes in- ducing lengthening of hospital stays by means of the Appropriateness Evaluation Protocol显示文摘 | Fontaine P Jacques J Gillain D et td | 2011 | Health Policy2011,99,1: | 1 |
| 7 | Wetting analysis and surface characterisation of coir fibres used as re- inforcement for composites 显示文摘 | Tran L Q N Fuentes C A Dupont Gillain C | 2011 | Colloids and Surfaces A: Physicochemical and Engineering Aspects2011,377,13: | 1 |
| 8 | Assessing the causes inducing lengthening of hospital stays by means of the Appropriateness Evaluation Protocol 显示文摘 | Fontaine P Jacques J Gillain D | 2011 | Health Policy2011,99,1: | 1 |
| 9 | Perisylvian dysgenesisclinical,EEG,MRI and glucose metabolism features in 10patients显示文摘 | Bogaert David P Gillain CA | 1998 | Brain1998,121,12: | 1 |
| 10 | Assessing the causes inducing lengthening of hospital stays by means of the Appropriateness Evalua- tion Protocol显示文摘 | Fontaine P Jacques J Gillain D et ol | 2011 | Health Policy2011,99,1: | 1 |
| 11 | The macro- cychc lactone spmosad , a promising insecticide for tsetse fly control显示文摘 | De Deken R Speybroeek N Gillain G | 2004 | J Med Entomol2004,41,5: | 1 |
| 12 | Wetting analysis and surface characterisation of coir fi bres used as reinforcement for composites显示文摘 | Tran L Q N Fuentes C A Dupont Gillain C | 2011 | Colloids and Surfaces A: Physicochemical and Engineering As- pects2011,377,1: | 1 |
| 13 | The value of instrumental gait analysis in elderly healthy, MCI or Alzheimer's disease subjects and a comparison with other clinical tests used in single and dual-task conditions显示文摘 | Gillain S Warzee E Lekeu F | 2009 | Ann Phys Rehabil Med2009,52,: | 1 |
| 14 | Development and validation of nursing resource weights for the Belgian Nursing Minimum Dataset in general hospitals: a Delphi questionnaire survey approach显示文摘 | Sermeus W Gillet P Gillain D | 2009 | Int J Nurs Stud2009,46,2: | 1 |
| 15 | Endoscopic ultrasound-guidedtransluminal drainage of pancreatic duct obstruction:long-termoutcome显示文摘 | Ergun M Aouattah T Gillain C | | 0,,06: | 1 |
| 16 | Endoscopic ultrasound-guided transluminal drainage of pancreatic duct obstruction: long-term outcome显示文摘 | M. Ergun T. Aouattah C. Gillain J.-F. Gigot C. Hubert P. Deprez | 2011 | Endoscopy2011,,06: | 1 |
| 17 | Belgian schizophrenia outcomesurvey-results of a 2-year naturalistic study in patients stabilisedon monotherapy with olanzapine,risperidone or haloperidol显示文摘 | Peuskens J Gillain B De-Graeve D | 2009 | EurPsychiatry2009,24,3: | 1 |
| 18 | Collagen adsorption on foly (nethyl methacrylate): net- like structure fomation upon drying显示文摘 | C C Dupont- Gillain B Nysten P G Rouxhet | 1999 | Polymer International1999,48,4: | 1 |
| 19 | Expanding the horizons of endoscopic ultrasound:diagnosis of non-digestive pathologies显示文摘Endoscopic ultrasound(EUS)is mainly used for the evaluation and sampling of mediastinal and abdominal lymph nodes,luminal and submucosal lesions of the upper and lower gastrointestinal tract,as well as in the diagnostic approach for pancreatic,biliary and liver disease.However,several non-digestive pathologies may be encountered as well,expanding the diagnostic potential of EUS.In this article,we present nine examples of extra-digestive abnormalities detected by means of EUS,including pathologies of the thyroid gland,mediastinal and abdominal vessels,lungs,kidney and the urinary bladder.The purpose of this article is to review the capabilities of EUS beyond routine evaluation of gastrointestinal organs. | Georgios Mavrogenis Hocine Hassaini Alain Sibille Sofia Feloni Pierre H.Deprez Cedric Gillain Philippe Warzee | 2014 | Gastroenterology Report2014,2,1: | 0 |
| 20 | Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome显示文摘BACKGROUND Lynch syndrome(LS)is a hereditary cancer predisposition syndrome associated with increased risk of multiple cancers.While colorectal cancer surveillance decreases mortality in LS and is recommended by guidelines,there is lack of evidence for the efficacy of surveillance for extra-colonic cancers associated with LS,including small intestinal cancer(SIC)and urinary tract cancer(UTC).Given the limited evidence,guidelines do not consistently recommend surveillance for SIC and UTC,and it remains unclear how often individuals will choose to undergo and follow through with extra-colonic surveillance recommendations.AIM To study factors associated with SIC and UTC surveillance uptake and outcomes in LS.METHODS This is an IRB-approved retrospective analysis of individuals with LS seen at a tertiary care referral center.Included individuals had a pathogenic or likely pathogenic variant in MLH1,MSH2,MSH6,PMS2,or EPCAM,or were a confirmed obligate carrier,and had at least one documented visit to our center.Information regarding SIC and UTC surveillance was captured for each individual,and detailed personal and family history was obtained for individuals who had an initial LS management visit in our center’s dedicated high-risk LS clinic between January 1,2017 and October 29,2020.During these initial management visits,all patients had in-depth discussions of SIC and UTC surveillance with 1 of 3 providers experienced in LS management to promote informed decision-making about whether to pursue SIC and/or UTC surveillance.Statistical analysis using Pearson’s chi-squared test and Wilcoxon rank-sum test was completed to understand the factors associated with pursuit and completion of SIC and UTC surveillance,and a P value below 0.05 was deemed statistically significant.RESULTS Of 317 individuals with LS,86(27%)underwent a total of 105 SIC surveillance examinations,with 5 leading to additional work-up and no SICs diagnosed.Additionally,99(31%)patients underwent a total of 303 UTC surveillance examinations,with 19 requiring further evaluation and 1 UTC identified.Of 155 individuals who had an initial LS management visit between January 1,2017 and October 29,2020,63(41%)chose to undergo SIC surveillance and 58(37%)chose to undergo UTC surveillance.However,only 26(41%)and 32(55%)of those who initially chose to undergo SIC or UTC surveillance,respectively,successfully completed their surveillance examinations.Individuals with a pathogenic variant in MSH2 or EPCAM were more likely to initially choose to undergo SIC surveillance(P=0.034),and older individuals were more likely to complete SIC surveillance(P=0.007).Choosing to pursue UTC surveillance was more frequent among older individuals(P=0.018),and females more frequently completed UTC surveillance(P=0.002).Personal history of cancer and family history of SIC or UTC were not significantly associated with electing nor completing surveillance.Lastly,the provider discussing SIC/UTC surveillance was significantly associated with subsequent surveillance choices.CONCLUSION Pursuing and completing SIC/UTC surveillance in LS is influenced by several factors,however broad incorporation in LS management is likely unhelpful due to low yield and frequent false positive results. | Jeshua DeJesse Ravy K Vajravelu Christina Dudzik Gillain Constantino Jessica M Long Kirk J Wangensteen Kathleen D Valverde Bryson W Katona | 2021 | World Journal of Clinical Oncology2021,12,11: | 0 |